Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KCNN4 | O15554 | 1/20 | 0.43 |
| ▸ | POLB | P06746 | 1/20 | 0.38 |
| ▸ | LMNA | P02545 | 1/20 | 0.37 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.37 |
| ▸ | CES1 | P23141 | 1/20 | 0.37 |
| ▸ | HTT | P42858 | 1/20 | 0.36 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.36 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.36 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.36 |
| ▸ | ATM | Q13315 | 1/20 | 0.35 |
| ▸ | TSHR | P16473 | 2/20 | 0.35 |
| ▸ | HDAC3 | O15379 | 1/20 | 0.35 |
| ▸ | HDAC4 | P56524 | 1/20 | 0.35 |
| ▸ | HDAC1 | Q13547 | 1/20 | 0.35 |
| ▸ | HDAC7 | Q8WUI4 | 1/20 | 0.35 |
| ▸ | HDAC2 | Q92769 | 1/20 | 0.35 |
| ▸ | HDAC10 | Q969S8 | 1/20 | 0.35 |
| ▸ | HDAC11 | Q96DB2 | 1/20 | 0.35 |
| ▸ | HDAC8 | Q9BY41 | 1/20 | 0.35 |
| ▸ | HDAC6 | Q9UBN7 | 1/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL15668595 | 1.00 | KCNN4 (0.43) | KCNN4POLBLMNAKMT2ACES1 | |
| SCHEMBL15668593 | 1.00 | KCNN4 (0.43) | KCNN4POLBLMNAKMT2ACES1 | |
| SCHEMBL6036537 | 1.00 | KCNN4 (0.43) | KCNN4POLBLMNAKMT2ACES1 | |
| SCHEMBL18649120 | 1.00 | KCNN4 (0.43) | KCNN4POLBLMNAKMT2ACES1 | |
| SCHEMBL5427678 | 1.00 | KCNN4 (0.43) | KCNN4POLBLMNAKMT2ACES1 | |
| SCHEMBL5196336 | 0.83 | MAPT (0.37) | KCNN4LMNAKMT2ACES1ALDH1A1 | |
| SCHEMBL5195703 | 0.83 | MAPT (0.37) | KCNN4LMNAKMT2ACES1ALDH1A1 | |
| SCHEMBL16498030 | 0.83 | MAPT (0.37) | KCNN4LMNAKMT2ACES1ALDH1A1 | |
| SCHEMBL3148024 | 0.81 | HTR2C (0.46) | KMT2AALDH1A1TDP1TSHRMAPK1 | |
| SCHEMBL30775651 | 0.81 | SSTR4 (0.36) | KCNN4KMT2ACES1ALDH1A1SMN1; SMN2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 28 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2026090509-A1 | SPIRO HETEROCYCLIC CDK2 INHIBITORS | ARCHITECT THERAPEUTICS, INC. (US) | 2026-04-30 | — | — | WO | disclosed |
| US-20260014146-A1 | CDK2 INHIBITORS AND METHODS OF USING THE SAME | CEDILLA THERAPEUTICS INC (US) | 2026-01-15 | — | — | US | disclosed |
| EP-4562014-A2 | CDK2 INHIBITORS AND METHODS OF USING THE SAME | Cedilla Therapeutics, Inc. (US) | 2025-06-04 | — | — | EP | disclosed |
| EP-4561575-A2 | CDK2 INHIBITORS AND METHODS OF USING THE SAME | Cedilla Therapeutics, Inc. (US) | 2025-06-04 | — | — | EP | disclosed |
| WO-2025011610-A1 | AMIDE DERIVATIVE, AND COMPOSITION AND USE THEREOF | 深圳市塔吉瑞生物医药有限公司 | 2025-01-16 | — | — | WO | disclosed |
| CN-119306790-A | Amide derivative, composition and use thereof | 深圳市塔吉瑞生物医药有限公司 | 2025-01-14 | — | — | CN | disclosed |
| US-20240277795-A1 | INHIBITORS OF CYSTEINE PROTEASES AND METHODS OF USE THEREOF | PARDES BIOSCIENCES INC (US) | 2024-08-22 | — | — | US | disclosed |
| US-12065445-B2 | CDK2 inhibitors and methods of using the same | CEDILLA THERAPEUTICS, INC. (US) | 2024-08-20 | — | — | US | disclosed |
| EP-4387980-A1 | INHIBITORS OF CYSTEINE PROTEASES AND METHODS OF USE THEREOF | Pardes Biosciences, Inc. (US) | 2024-06-26 | — | — | EP | disclosed |
| US-20240174680-A1 | CDK2 INHIBITORS AND METHODS OF USING THE SAME | CEDILLA THERAPEUTICS, INC. (US) | 2024-05-30 | — | — | US | disclosed |
| US-8143418-B2 | Dimeric small molecule potentiators of apoptosis | BOARD OF REGENTS, THE UNIVERSITY OF TEXAS SYSTEM (US) | 2012-03-27 | — | — | US | disclosed |
| US-20110124585-A1 | Dimeric Small Molecule Potentiators of Apoptosis | BOARD OF REGENTS | 2011-05-26 | — | — | US | disclosed |
| US-7884211-B2 | 2-Methylamino-N-{2-(6-{1-methyl-2-(2-methylamino-propionylamino)-3-oxo-3-[2-(5-phenoxy-tetrazol-1-ylmethyl)-pyrrolidine-1-yl]-propoxy}-hexa-2,4-diynyloxy)-1-[2-(5-phenoxy-tetrazol-1-ylmethyl)-pyrrolidine-1-carbonyl]-propyl}-propionamide; mimetics of second mitochondria-derived activator of caspases | BOARD OF REGENTS, THE UNIVERSITY OF TEXAS SYSTEM (US) | 2011-02-08 | — | — | US | disclosed |
| US-7816538-B2 | Dimeric small molecule potentiators of apoptosis | BOARD OF REGENTS, THE UNIVERSITY OF TEXAS SYSTEM (US) | 2010-10-19 | — | — | US | disclosed |
| US-7638544-B2 | Dimeric small molecule potentiators of apoptosis | BOARD OF REGENTS, THE UNIVERSITY OF TEXAS SYSTEM (US) | 2009-12-29 | — | — | US | disclosed |
| US-20090312379-A1 | Dimeric Small Molecule Potentiators of Apoptosis | NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT | 2009-12-17 | — | — | US | disclosed |
| US-20090281155-A1 | Dimeric Small Molecule Potentiators of Apoptosis | BOARD OF REGENTS, THE UNIVERSITY OF TEXAS SYSTEM | 2009-11-12 | — | — | US | disclosed |
| US-20080119532-A1 | Dimeric Small Molecule Potentiators of Apoptosis | BOARD OF REGENTS, THE UNIVERSITY OF TEXAS SYSTEM | 2008-05-22 | — | — | US | disclosed |
| US-7309792-B2 | Dimeric small molecule potentiators of apoptosis | BOARD OF REGENTS, THE UNIVERSITY OF TEXAS SYSTEM (US) | 2007-12-18 | — | — | US | disclosed |
| US-20050197403-A1 | Dimeric small molecule potentiators of apoptosis | BOARD OF REGENTS, THE UNIVERSITY OF TEXAS SYSTEM | 2005-09-08 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (9 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20090312379-A1 | Dimeric Small Molecule Potentiators of Apoptosis | BAD, BAX, CASP2 | KCNN4 4747/4885POLB 983/4885LMNA 85/4885 |
| US-20090281155-A1 | Dimeric Small Molecule Potentiators of Apoptosis | BAD, BAX, CASP2 | KCNN4 4747/4885POLB 983/4885LMNA 85/4885 |
| US-20240174680-A1 | CDK2 INHIBITORS AND METHODS OF USING THE SAME | CDK2, CDK20, CDK2AP2 | KCNN4 4772/4885POLB 144/4885LMNA 792/4885 |
| US-20110124585-A1 | Dimeric Small Molecule Potentiators of Apoptosis | BAD, BAX, CASP2 | KCNN4 4747/4885POLB 983/4885LMNA 85/4885 |
| US-20080119532-A1 | Dimeric Small Molecule Potentiators of Apoptosis | BAD, BAX, CASP2 | KCNN4 4730/4885POLB 1035/4885LMNA 93/4885 |
| US-20240277795-A1 | INHIBITORS OF CYSTEINE PROTEASES AND METHODS OF USE THEREOF | CTRL, CPN1, CTSL | KCNN4 4745/4885POLB 2783/4885LMNA 2949/4885 |
| US-20050197403-A1 | Dimeric small molecule potentiators of apoptosis | BAD, BAX, CASP2 | KCNN4 4734/4885POLB 959/4885LMNA 94/4885 |
| US-12065445-B2 | CDK2 inhibitors and methods of using the same | CDK2, CDK20, CDK1 | KCNN4 4649/4885POLB 216/4885LMNA 971/4885 |
| US-20260014146-A1 | CDK2 INHIBITORS AND METHODS OF USING THE SAME | CDK2, CDK20, CDK1 | KCNN4 3757/4885POLB 126/4885LMNA 1379/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.